Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques

被引:80
作者
von Wolff, Michael [1 ,6 ]
Germeyer, A. [2 ]
Liebenthron, J. [3 ]
Korell, M. [4 ]
Nawroth, F. [5 ]
机构
[1] Med Univ Berne, Div Gynaecol Endocrinol & Reprod Med, Bern, Switzerland
[2] Med Univ Heidelberg, Dept Gynaecol Endocrinol & Fertil Disorders, Heidelberg, Germany
[3] Med Univ Bonn, Dept Gynaecol Endocrinol & Reprod Med, Bonn, Germany
[4] Johanna Etienne Hosp Neuss, Dept Obstet & Gynaecol, Neuss, Germany
[5] Amedes Hamburg, Ctr Infertil Prenatal Med Endocrinol & Osteol, Hamburg, Germany
[6] Inselspital Bern, Univ Womens Hosp, Div Gynaecol Endocrinol & Reprod Med, Effingerstr 102, CH-3010 Bern, Switzerland
关键词
Fertility preservation; Ovarian tissue; Oocyte ovarian stimulation; GnRH agonists; CONTROLLED OVARIAN STIMULATION; IN-VITRO FERTILIZATION; EMBRYO-TRANSFER CYCLES; BREAST-CANCER; PELVIC RADIOTHERAPY; POSTPONE MENOPAUSE; HORMONE AGONISTS; LIVE-BIRTH; TISSUE; CHEMOTHERAPY;
D O I
10.1007/s00404-017-4595-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose In addition to guidelines focusing on scientific evidence, practical recommendations on fertility preservation are also needed. Methods A selective literature search was performed based on the clinical and scientific experience of the authors. This article (Part II) focuses on fertility preservation techniques. Part I, also published in this journal, provides information on disease prognosis, disease-specific therapy, and risks for loss of fertility. Results Ovarian stimulation including double stimulation and freezing of oocytes is the best-established therapy providing live birth chances in women < 35 years with high ovarian reserve of around 30-40%. Ovarian tissue freezing is especially useful in young women with good ovarian, if spontaneous conception is favoured and if < 1 week until chemotherapy is provided. Data on success rates are still limited, but this further evolving technique will possibly reach similar success rates as ovarian stimulation. GnRH agonists seem to reduce the risk of premature ovarian failure up to 50%; however, the effect is possibly not long-lasting. Ovarian transposition can easily be combined with freezing of ovarian tissue and is the preferred technique before pelvic radiotherapy. Other techniques, such as in vitro maturation, are limited to women with high ovarian reserve and remain less effective. In addition, procedures such as in vitro growth of follicles, etc. are still experimental. Conclusions Fertility preservation in women provides realistic chances of becoming pregnant. The choice of technique needs to be based on the time required, the woman's age, its risks and efficacy, and the individual preference of the patient.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 59 条
[1]  
Alvarez RM, 2016, HUM REPROD
[2]   Novel use of the ovarian follicular pool to postpone menopause and delay osteoporosis [J].
Andersen, Claus Yding ;
Kristensen, Stine Gry .
REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 31 (02) :128-131
[3]   Ovarian stimulation in the luteal phase: systematic review and meta-analysis [J].
Boots, C. E. ;
Meister, M. ;
Cooper, A. R. ;
Hardi, A. ;
Jungheim, E. S. .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2016, 33 (08) :971-980
[4]   Effective method for emergency fertility preservation: random-start controlled ovarian stimulation [J].
Cakmak, Hakan ;
Katz, Audra ;
Cedars, Marcelle I. ;
Rosen, Mitchell P. .
FERTILITY AND STERILITY, 2013, 100 (06) :1673-1680
[5]   Fertility Preservation with Immature and in Vitro Matured Oocytes [J].
Cao, Yun-Xia ;
Chian, Ri-Cheng .
SEMINARS IN REPRODUCTIVE MEDICINE, 2009, 27 (06) :456-464
[6]   Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles [J].
Chen, Hong ;
Wang, Yun ;
Lyu, Qifeng ;
Ai, Ai ;
Fu, Yonglun ;
Tian, Hui ;
Cai, Renfei ;
Hong, Qingqing ;
Chen, Qiuju ;
Shoham, Zeev ;
Kuang, Yanping .
FERTILITY AND STERILITY, 2015, 103 (05) :1194-+
[7]   No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial [J].
Demeestere, Isabelle ;
Brice, Pauline ;
Peccatori, Fedro A. ;
Kentos, Alain ;
Dupuis, Jehan ;
Zachee, Pierre ;
Casasnovas, Olivier ;
Van Den Neste, Eric ;
Dechene, Julie ;
De Maertelaer, Viviane ;
Bron, Dominique ;
Englert, Yvon .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (22) :2568-U35
[8]   Live birth after autograft of ovarian tissue cryopreserved during childhood [J].
Demeestere, Isabelle ;
Simon, Philippe ;
Dedeken, Laurence ;
Moffa, Federica ;
Tsepelidis, Sophie ;
Brachet, Cecile ;
Delbaere, Anne ;
Devreker, Fabienne ;
Ferster, Alina .
HUMAN REPRODUCTION, 2015, 30 (09) :2107-2109
[9]   Xenotransplantation of cryopreserved human ovarian tissue-a systematic review of MII oocyte maturation and discussion of it as a realistic option for restoring fertility after cancer treatment [J].
Dittrich, Ralf ;
Lotz, Laura ;
Fehm, Tanja ;
Kruessel, Jan ;
von Wolff, Michael ;
Toth, Bettina ;
van der Ven, Hans ;
Schuering, Andreas N. ;
Wuerfel, Wolfgang ;
Hoffmann, Inge ;
Beckmann, Matthias W. .
FERTILITY AND STERILITY, 2015, 103 (06) :1557-1565
[10]   Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes [J].
Dolmans, Marie-Madeleine ;
Marotta, Maria-Laura ;
Pirard, Celine ;
Donnez, Jacques ;
Donnez, Olivier .
JOURNAL OF OVARIAN RESEARCH, 2014, 7